by Dr. Reinhard Hiller | Sep 22, 2014 | Blog, Emerging markets, Innovation management, The "Omics" Revolution
Yes! If a set of other components is in place to make a complex innovation equation work… Introduction Genomics holds great promises for drug development through the identification of new drug targets, better understanding of disease mechanism, and the elucidation of...
by Dr. Reinhard Hiller | Sep 19, 2014 | Blog, Emerging markets, The "Omics" Revolution
My short answer to this is, yes, but the real value of Genomics goes beyond an economic return and cannot be captured easily in dollars and cents! Background According to US-based non-profit research organisation Battelle, the Human Genome Project (HGP) contributed...
by Dr. Reinhard Hiller | Jan 6, 2012 | Blog, The "Omics" Revolution
I have recently explored the development of the biggest Genomics facility in the world at present, the BGI in China, to contextualize what kind of role Africa can play in the ‘omics’ revolution. Here, I am starting to investigate some of the challenges the ‘omics’...
by Dr. Reinhard Hiller | Dec 21, 2011 | Blog, The "Omics" Revolution
Can Africa play a role in the ‘omics’ revolution? This is a question that I am being asked frequently by colleagues locally and internationally. If yes, what role could it be? I’d like to explore the role Africa can play through 3 different lenses: China’s role as an...
by Dr. Reinhard Hiller | Dec 20, 2011 | Blog, The "Omics" Revolution
In a recent blog on Harvard Business Reviews online, Vijay Govindarajan and Justin Chakma argued that some VC firms operating in emerging economies follow a systems-based philosophy when making investment decisions. More specifically, some of these companies treat...
Recent Comments